Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Dopamine, the prefrontal cortex and schizophrenia.

Knable MB, Weinberger DR.

J Psychopharmacol. 1997;11(2):123-31. Review.

PMID:
9208376
2.

Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.

Deakin FW, Simpson MD, Slater P, Hellewell JS.

J Psychopharmacol. 1997;11(2):133-42. Review.

PMID:
9254279
3.

The role of limbic and cortical regions in schizophrenia: focus on dopamine.

Marchese G, Pani L.

Eur Psychiatry. 2002 Aug;17 Suppl 4:349s-354s.

PMID:
23573604
4.

[Deficit schizophrenia: from pharmacology to clinical practice].

Tassin JP.

Encephale. 1996 Jun;22 Spec No 2:9-12. Review. French.

PMID:
8767035
5.

Schizophrenic deficits: neuroleptics and the prefrontal cortex.

Jobe TH, Harrow M, Martin EM, Whitfield HJ, Sands JR.

Schizophr Bull. 1994;20(3):413-6; discussion 417-21.

PMID:
7973463
6.

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground.

Weinberger DR, Lipska BK.

Schizophr Res. 1995 Aug 1;16(2):87-110. Review.

PMID:
7577773
7.

[Genetic and pharmacological effects on prefrontal cortical function in schizophrenia].

Heinz A, Braus DF, Romero B, Gallinat J, Puls I, Juckel G, Weinberger DR.

Nervenarzt. 2004 Sep;75(9):845-56. Review. German.

PMID:
15372159
8.

Model-based parametric study of frontostriatal abnormalities in schizophrenia patients.

Tanaka S.

BMC Psychiatry. 2010 Feb 27;10:17. doi: 10.1186/1471-244X-10-17. Erratum in: BMC Psychiatry. 2010;10:93.

9.

Dopamine neurotransmission and atypical antipsychotics in prefrontal cortex: a critical review.

Masana M, Santana N, Artigas F, Bortolozzi A.

Curr Top Med Chem. 2012;12(21):2357-74. Review.

PMID:
23279176
10.

The dopamine hypothesis of schizophrenia revisited.

van Kammen DP.

Psychoneuroendocrinology. 1979 Jan;4(1):37-46. No abstract available.

PMID:
39306
11.

Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.

Tanaka S.

Neuroscience. 2006 Apr 28;139(1):153-71. Epub 2005 Dec 1. Review.

PMID:
16324800
12.

[Psychopharmacologic approaches to schizophrenic psychoses].

Giacardy-Paty M, Soubrouillard C, Blin O.

Encephale. 1995 Jun;21 Spec No 3:3-8. Review. French.

PMID:
7628339
13.

Mesocortical neurotensin/dopamine system: is it involved in the pathogenesis of schizophrenia?

Satoh K.

Jpn J Psychiatry Neurol. 1991 Jun;45(2):503-6. No abstract available.

PMID:
1722262
14.

[The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].

Maćkowiak M, Czyrak A, Wedzony K.

Psychiatr Pol. 2000 Jul-Aug;34(4):607-21. Review. Polish.

PMID:
11059260
15.

Functional and anatomical aspects of prefrontal pathology in schizophrenia.

Goldman-Rakic PS, Selemon LD.

Schizophr Bull. 1997;23(3):437-58. Review.

PMID:
9327508
16.

Schizophrenia: D4 receptor elevation. What does it mean?

Seeman MV.

J Psychiatry Neurosci. 1994 May;19(3):171-6. Review. No abstract available.

17.

Executive functioning component mechanisms and schizophrenia.

Kerns JG, Nuechterlein KH, Braver TS, Barch DM.

Biol Psychiatry. 2008 Jul 1;64(1):26-33. doi: 10.1016/j.biopsych.2008.04.027.

PMID:
18549874
18.

Preferential activation of cortical dopamine neurotransmission by clozapine: functional significance.

Moghaddam B.

J Clin Psychiatry. 1994 Sep;55 Suppl B:27-9. Review.

PMID:
7961567
19.
20.

The prefrontal cortex: a target for antipsychotic drugs.

Artigas F.

Acta Psychiatr Scand. 2010 Jan;121(1):11-21. doi: 10.1111/j.1600-0447.2009.01455.x. Review.

PMID:
20059453

Supplemental Content

Support Center